Royalty Pharma plc (RPRX) Insider Trading
- $144,650,981.16
- $569,823,010.16
- Jan. 4, 2024
- Rory B Riggs
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 4, 2024 | Director | 35,702 | $27.55 | Sell | $983,590.10 | |
| Jan. 2, 2024 | Director | 235,200 | $28.52 | Sell | $6,707,904.00 | |
| Dec. 27, 2023 | Major Shareholder | 41,729 | $28.01 | Sell | $1,168,829.29 | |
| Aug. 9, 2023 | CFO | 37,500 | $30.72 | Sell | $1,152,000.00 | |
| July 12, 2023 | CFO | 37,500 | $31.07 | Sell | $1,165,125.00 | |
| June 28, 2023 | CEO | 130,000 | $29.51 | Buy | $3,836,300.00 | |
| June 12, 2023 | CEO | 45,000 | $33.00 | Buy | $1,485,000.00 | |
| June 5, 2023 | EVP | 19,215 | $33.54 | Sell | $644,471.10 | |
| June 2, 2023 | EVP | 93,907 | $33.64 | Sell | $3,159,031.48 | |
| May 24, 2023 | CEO | 150,000 | $32.25 | Buy | $4,837,500.00 | |
| May 22, 2023 | Director | 1,750,000 | $32.82 | Sell | $57,435,000.00 | |
| May 16, 2023 | CEO | 160,388 | $33.57 | Buy | $5,384,225.16 | |
| March 29, 2023 | Director | 9,926 | $36.95 | Sell | $366,765.70 | |
| March 28, 2023 | EVP | 100,000 | $37.06 | Sell | $3,706,000.00 | |
| Dec. 12, 2022 | Director | 40,010 | $41.98 | Sell | $1,679,619.80 | |
| Dec. 5, 2022 | Director | 84,302 | $43.15 | Sell | $3,637,631.30 | |
| Nov. 21, 2022 | EVP | 23,631 | $43.11 | Sell | $1,018,732.41 | |
| Nov. 17, 2022 | Director | 120,000 | $42.33 | Sell | $5,079,600.00 | |
| Nov. 8, 2022 | CFO | 24,500 | $43.47 | Sell | $1,065,015.00 | |
| Sept. 28, 2022 | Director | 32,593 | $41.05 | Sell | $1,337,942.65 | |
| Sept. 28, 2022 | EVP | 100,000 | $41.23 | Sell | $4,123,000.00 | |
| Sept. 21, 2022 | Director | 125,697 | $41.25 | Sell | $5,185,001.25 | |
| Sept. 20, 2022 | Major Shareholder | 267,815 | $41.02 | Sell | $10,985,771.30 | |
| Sept. 19, 2022 | Director | 232,185 | $41.50 | Sell | $9,635,677.50 | |
| Sept. 16, 2022 | Director | 154,986 | $41.72 | Sell | $6,466,015.92 | |
| Aug. 9, 2022 | EVP | 11,859 | $43.92 | Sell | $520,847.28 | |
| Aug. 9, 2022 | Director | 45,000 | $43.73 | Sell | $1,967,850.00 | |
| Aug. 1, 2022 | CFO | 30,000 | $43.19 | Sell | $1,295,700.00 | |
| July 27, 2022 | EVP | 25,100 | $43.76 | Sell | $1,098,376.00 | |
| July 25, 2022 | EVP | 30,671 | $42.93 | Sell | $1,316,706.03 | |
| June 29, 2022 | Director | 30,000 | $42.17 | Sell | $1,265,100.00 | |
| June 24, 2022 | EVP | 23,333 | $43.19 | Sell | $1,007,752.27 | |
| May 27, 2022 | EVP | 75,000 | $41.08 | Sell | $3,081,000.00 | |
| May 23, 2022 | EVP | 100,000 | $40.27 | Sell | $4,027,000.00 | |
| May 19, 2022 | Director | 26,304 | $40.09 | Sell | $1,054,527.36 | |
| May 19, 2022 | EVP | 75,000 | $40.44 | Sell | $3,033,000.00 | |
| May 16, 2022 | EVP | 23,333 | $39.85 | Sell | $929,820.05 | |
| March 29, 2022 | Director | 60,000 | $38.59 | Sell | $2,315,400.00 | |
| March 21, 2022 | Director | 39,867 | $39.05 | Sell | $1,556,806.35 | |
| March 18, 2022 | Director | 129,222 | $39.55 | Sell | $5,110,730.10 | |
| Feb. 24, 2022 | Director | 32,500 | $37.49 | Buy | $1,218,425.00 | |
| Dec. 28, 2021 | Director | 109,448 | $40.21 | Sell | $4,400,904.08 | |
| Nov. 16, 2021 | EVP | 165,852 | $42.39 | Sell | $7,030,466.28 | |
| Nov. 16, 2021 | Director | 12,565 | $42.01 | Sell | $527,855.65 | |
| Sept. 28, 2021 | Director | 40,000 | $36.75 | Sell | $1,470,000.00 | |
| July 26, 2021 | EVP | 13,362 | $39.78 | Sell | $531,540.36 | |
| July 14, 2021 | EVP | 2 | $42.00 | Sell | $84.00 | |
| July 12, 2021 | EVP | 100 | $42.04 | Sell | $4,204.00 | |
| July 8, 2021 | EVP | 40,655 | $42.05 | Sell | $1,709,542.75 | |
| July 6, 2021 | EVP | 30,270 | $42.40 | Sell | $1,283,448.00 |
Insiders are both buying and selling Royalty Pharma plc stock.
The insider traders at Royalty Pharma plc are: Rory B Riggs, George W Lloyd, Terrance P Coyne, Pablo G Legorreta, James F Reddoch, Mario Germano Giuliani, Marshall Urist, Henry A Fernandez, Adage Capital Partners Gp, L.L, James F. Reddoch, William E Ford, Avara Management Ltd, and 1978 Sicaf Sif S.A. - Gg St Gg
The most active insider trader at Royalty Pharma plc is Rory B Riggs with 18 trades.
Adage Capital Partners Gp, L.L has sold the most Royalty Pharma plc stock with a total value of $641,324,232.00.
Adage Capital Partners Gp, L.L has bought the most Royalty Pharma plc stock with a total value of $168,000,000.00.
The most recent insider trade for Royalty Pharma plc was on Jan. 4, 2024.
The single biggest insider buy for Royalty Pharma plc was from Adage Capital Partners Gp, L.L with a total value of $84,000,000.00 on June 18, 2020.
The single biggest insider sell for Royalty Pharma plc was from Adage Capital Partners Gp, L.L with a total value of $320,662,116.00 on Dec. 18, 2020.